IMR Press / CEOG / Special Issues / 1632301019571

State-of-the-Art of Obstetrics and Gynecology in Italy

Submission deadline: 20 September 2022
Special Issue Editors
Luca Roncati, MD
Department of Surgery, Medicine, Dentistry and Morphological Sciences with interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy
Interests: gynaecopathology; gynaecological oncology; molecular oncology; human papilloma virus; PAP smear; breast cancer; target therapy; precision oncology; endocrine disruptors
Special Issue and Collections in IMR journals
Special Issue Information

Dear Colleagues,

Clinical and Experimental Obstetrics & Gynecology (CEOG) was founded in 1974 by the Italian gynecologist Prof. Antonio Onnis; after almost 50 years, the discipline has made great strides in Italy. Today, the obstetric part is more and more independent from the gynecological oncology, which is now an ultra-specialized branch enriched by clinical-pathological correlations, not only for the ascertained role of Human Papilloma Virus (HPV) in oncogenesis and the consequent introduction of HPV-test in cervical cancer screening next to pap smear, but also for the availability of diagnostic, prognostic, and predictive immunohistochemistry and for the possibility of genomic profiling in female tumors through next-generation sequencing. Conceived as a tribute to CEOG founder, this special issue aims to illustrate by means of a multidisciplinary approach the state-of-the-art of obstetrics and gynecology in Italy, with particular reference to: miscarriage prevention, intrauterine unexplained death, sudden unexpected post-natal collapse, Coronavirus Disease 2019 (COVID-19) in pregnancy, thin layer pap smear, pap smear in the modern era, HPV test, HPV in situ hybridization, HPV vaccination, theranostics, minimally invasive surgery, robotic surgery, molecular gynecological oncology, mismatch repair deficiency, immunotherapy, targeted therapy, and personalized oncology.

Prof. Dr. Luca Roncati

Guest Editor

Keywords
Obstetrics
Gynecology
Gynecological pathology
Gynecological oncology
Pap smear
Human Papilloma Virus (HPV)
Immunohistochemistry
Immunotherapy
Personalized medicine
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top